This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
10/06/15 - 3:59:58 PM ET (BATS BZX Real-time Price)
Div Yield: --
ISIS Day's Range
ISIS 52 Week Range
ISIS Business Summary
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform.View ISIS key stats
ISIS Pharmaceuticals Inc - ISIS - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates ISIS Pharmaceuticals Inc as a
Hold with a ratings score of C.
Report Snippet: We rate ISIS PHARMACEUTICALS INC (ISIS) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income and good cash flow from operations. However, as a counter to these strengths, we find that the company has favored debt over equity in the management of its balance sheet.